Document Detail


Ventriculovascular coupling in systolic and diastolic heart failure.
MedLine Citation:
PMID:  17543251     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Pressure-volume analysis has provided critical insight into ventricular mechanics, and it has elucidated the underlying mechanisms of heart failure (HF). Renewed interest in ventriculovascular coupling, the interaction of the left ventricle and the arterial system, has developed from recent investigations focusing on the importance of heart rate control in systolic HF, blood pressure lability in the elderly, and acute pulmonary edema in patients with HF and a normal ejection fraction. These data suggest that abnormal ventriculovascular coupling may be an additional pathophysiologic mechanism underlying the development of HF with a normal ejection fraction and may provide a target for novel therapies.
Authors:
Justin M Fox; Mathew S Maurer
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  8     ISSN:  1523-3782     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2006 May 
Date Detail:
Created Date:  2007-06-04     Completed Date:  2007-08-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  232-9     Citation Subset:  -    
Affiliation:
Clinical Cardiovascular Research Laboratory for the Elderly, Allen Pavilion of New York Presbyterian Hospital, 5141 Broadway, 3 Field West, Room 035, New York, NY 10034, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections
Republished from:
Curr Heart Fail Rep. 2005 Dec;2(4):204-11   [PMID:  16332314 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The frequency, impact, and management of mitral regurgitation in patients with heart failure.
Next Document:  Metformin and glitazones: do they really help PCOS patients?